Guerbet at ECIO 2025
Lipiodol UltraFluid in HCC
ECIO | April 13th to 16th | Rotterdam, NL
JOIN OUR SYMPOSIUM
TACE in HCC Management: A Multifaceted Approach
Tuesday, April 15th (12:30 - 13:15 CET) - Auditorium 2/SY 331
Tumor Tagging for Advanced Ablation Guidance, Combined TACE + Ablation Approaches
Prof. Maxime Ronot
Hospital Practitioner (APHP) / Head of the Department of Medical Imaging at Beaujon University Hospital in Clichy, (Paris, FR)
Towards Super Selective & Reproducible TACE: How Can We Improve Our Practices
Prof. Lambros Tselikas
Hospital Practitioner – University Professor, Interventional Radiologist and Head of the Department of Anesthesia, Surgery, and Interventional Radiology (DACI) at Gustave Roussy,
(Villejuif, FR)
Lipiodol® as a Biomarker Surrogate for Tumor Response Assessment
Prof. Thomas Joseph Vogl
Professor of radiography at the University of Frankfurt and Director of the Institute for Diagnostic and Interventional Radiology at the University Hospital Frankfurt/Main,
(Frankfurt, DE)
Add to calendar
JOIN OUR BOOTH #14
HANDS-ON EXPERIENCE: Create a water-in-oil emulsion using Qitexio® and test our arterial flow model!
Prepare your hands-on experience!
This information is intended for Health Care Professional only. It's intended for international audience or is provided during an international event. Lipiodol® Ultra Fluid (Ethyl esters of iodized fatty acids of poppy seed oil) is not registered in all countries. Be aware that Indications, posology, and presentations may differ from country to country. For current and complete prescribing information refer to the local Summary of Product Characteristics (SmPC) and /or contact your local Guerbet organization. For the SmPC of Lipiodol® and IFU of Qitexio®, please scan the QR code
© Guerbet Group 2025
P25003451 – March 2025